SCIENTURE HOLDINGS, INC. Other Non-Current Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) had Other Non-Current Liabilities of $776.57 thousand as of 2023-06-30, per its 10-Q filed 2023-08-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-08-18
- 2023-06-30: Other Liabilities, Noncurrent $776.57K.
- 2023-03-31: Other Liabilities, Noncurrent $832.48K.
- 2022-12-31: Other Liabilities, Noncurrent $887.03K.
- 2022-09-30: Other Liabilities, Noncurrent $938.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-06-30 | $776.57K 10-Q · filed 2023-08-18 |
| 2023-03-31 | $832.48K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $887.03K 10-Q · filed 2023-08-18 |
| 2022-09-30 | $938.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $988.18K 10-Q · filed 2022-07-25 |
| 2021-12-31 | $1.07M 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |